Does Medicare cover Zepbound? Yes for sleep apnea (2026)
Two routes, and which one is yours depends on the diagnosis, not on the plan. Zepbound for moderate to severe obstructive sleep apnea is an ordinary Part D drug. Zepbound for weight alone is excluded from Part D by statute and reachable only through CMS's GLP-1 Bridge — and only as the KwikPen.
Does Medicare cover Zepbound?
Yes for moderate to severe obstructive sleep apnea in adults with obesity. That indication is not weight loss, so the statutory exclusion does not reach it, and a Part D plan can cover Zepbound for it, usually behind prior authorisation. For weight alone no Part D plan can. The Medicare GLP-1 Bridge covers the Zepbound KwikPen, not the vials or single-dose pens, for $50 a month until 31 December 2027 — and if you have moderate to severe sleep apnea you are excluded from the Bridge, because your Part D plan is the route.
When Part D covers it: sleep apnea
The FDA approved Zepbound for moderate to severe obstructive sleep apnea in adults with obesity in December 2024. The Social Security Act lets a drug programme exclude “agents when used for anorexia, weight loss, or weight gain” — a use, not a molecule — so the same pen is a Part D drug when it is prescribed for sleep apnea and is not when it is prescribed for weight.
At a denial, look at the diagnosis on the request before anything else. A prior authorisation submitted for weight is refused whatever else is true; the same drug requested for sleep apnea, with the diagnosis documented, is judged on the plan's own criteria instead.
Once a Part D plan covers it, what you pay counts toward the $2,100 out-of-pocket cap for 2026, after which covered drugs cost nothing more that year.
Read from FDA prescribing information for ZEPBOUND, via DailyMed and Social Security Act §1927(d)(2). Tirzepatide for type 2 diabetes is sold as Mounjaro, and Part D covers it on that indication. Medicare and Mounjaro →
For weight alone: the GLP-1 Bridge
Zepbound is on it. Only the KwikPen. Medicare's own page says the Bridge “doesn't cover single-dose Zepbound vials or pens”, so ask for the KwikPen by name: a prescription written for vials will not go through it.
It runs 1 July 2026 to 31 December 2027 at $50 a month. You must be 18 or older, have Medicare drug coverage, and when you start have one of:
- a BMI of 35 or higher
- a BMI of 30 or higher with diastolic heart failure (heart failure with preserved ejection fraction), uncontrolled high blood pressure, or chronic kidney disease at stage 3a or worse
- a BMI of 27 or higher with prediabetes, a previous heart attack or stroke, or peripheral artery disease with symptoms
You are not eligible if a Part D plan already covers your GLP-1, or if you have type 2 diabetes, moderate to severe sleep apnea or fatty liver disease — for those, Medicare's own page says, the route is your Part D plan.
Your prescriber sends the prescription and, when asked, a prior authorisation certifying that you are using the drug as part of a lifestyle programme focused on diet and exercise. Approval lasts through 31 December 2027, refills and dose changes included, unless you switch drug.
Weight loss drugs: the Medicare GLP-1 Bridge, Medicare.gov · Medicare GLP-1 Bridge, CMS, both read 10 September 2026.
What Zepbound costs on each route
| Route | What you pay |
|---|---|
| Part D, for moderate to severe sleep apnea | Your plan's tier for it; counts toward the $2,100 out-of-pocket cap for 2026 |
| GLP-1 Bridge, for weight | $50 a month. The $50 sits outside Part D: the deductible does not apply, and none of it counts toward the out-of-pocket cap. |
| Manufacturer savings card | Not usable by anyone on Medicare — federal anti-kickback rules |
| Cash, no insurance | $449 a month once titrated, read from its own published page on 2026-08-19 |
Cash price checked 2026-08-19. It does not count toward the Part D cap.
If your plan says no
72 hours for a standard coverage determination and 24 for an expedited one; for an exception the clock starts when the prescriber's supporting statement arrives. 60 days from the notice to ask the plan for a redetermination, longer if you show good cause. 42 CFR 423.568; 42 CFR 423.572; 42 CFR 423.582
- Model Coverage Determination Request Form, CMS — The form a Part D plan must accept for a coverage determination or exception request. CMS publishes it as a zip with the instructions; plans may use their own version, and yours must accept this one.
- Exceptions, CMS — What a formulary exception is, and the deadlines a plan is held to: 72 hours for a standard request, 24 for an expedited one, counted from when the prescriber's supporting statement arrives rather than from your call.
- Model Redetermination Request Form, CMS — The first-level appeal after a denial, effective 1 January 2025. You have 60 days from the denial notice.
At a denial, the appeal letter builder fills in the indication and the criterion; it runs in your browser and sends nothing.
The law this page rests on
The exclusion is a statute, the Bridge is a CMS demonstration, and the cap is set each year by CMS.
- Social Security Act §1927(d)(2), Office of the Law Revision Counsel — The statute itself, listing “agents when used for anorexia, weight loss, or weight gain” among the drugs a programme may exclude.
- Manufacturer safeguards may not prevent copayment coupon use for Part D drugs, HHS Office of Inspector General — Why a manufacturer copay card cannot be used with a federal programme, from the office that enforces it.
- Weight-loss drugs, Medicare.gov — Medicare's own page on what it does and does not cover for weight loss.
Medicare and Zepbound, answered
- Does Medicare cover Zepbound for sleep apnea?
- Yes. Moderate to severe obstructive sleep apnea in adults with obesity is an FDA-approved indication that is not weight loss, so a Part D plan can cover it, usually with prior authorisation, and what you pay counts toward the 2026 out-of-pocket cap of $2,100. People with moderate to severe sleep apnea cannot use the GLP-1 Bridge, because Part D is their route.
- Does the Medicare GLP-1 Bridge cover Zepbound vials?
- No. Medicare.gov lists Zepbound for the Bridge as “KwikPen only” and says the programme does not cover single-dose vials or pens. The KwikPen costs $50 a month there.
- Can I use the Zepbound savings card with Medicare?
- No. Federal anti-kickback rules bar a manufacturer from subsidising a copay inside a federal health programme, which is why the card says it is for the commercially insured. For weight, the Medicare route is the Bridge, not the card.